Announced Tue, 18 Nov · 09:50 IST
Trading Members of the Exchange are hereby informed that effective from November 18, 2025, the Equity Shares of Mahamaya Lifesciences Ltd (Scrip Code: 544611) are listed and admitted to ....
Capital Market EventsExplain this filing
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
—1-day move
—
prior close
₹116.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+5.0+0.0+0.9——————————
Up moveDown movePending
AI summary
Mahamaya Lifesciences Ltd has been listed and admitted to trading on BSE effective November 18, 2025, under scrip code 544611. The announcement informs trading members about the commencement of trading in the company's equity shares. This marks the company's entry into the public market via the BSE platform.
Likely market impact
The stock will be available for trading from November 18, 2025, giving investors an opportunity to buy shares of Mahamaya Lifesciences. Early trading periods for newly listed stocks often see price volatility as the market discovers a fair price.